Valuation: Dr. Reddy's Laboratories Limited

Market Cap 960B 9.97B 8.76B 8.14B 7.47B 14.04B 14.26B 96.7B 37.78B 472B 37.43B 36.62B 1,632B P/E 2027 *
25.3x
P/E 2028 * 19.6x
Enterprise Value 929B 9.64B 8.47B 7.88B 7.23B 13.58B 13.79B 93.52B 36.54B 456B 36.2B 35.42B 1,578B EV / Sales 2027 *
2.64x
EV / Sales 2028 * 2.31x
Free-Float
70.08%
Yield 2027 *
0.66%
Yield 2028 * 0.73%
1 day-1.19%
1 week-4.81%
Current month-15.05%
1 month-13.23%
3 months-12.41%
6 months-6.68%
Current year-9.32%
1 week 1,080.05
Extreme 1080.05
1,231
1 month 1,080.05
Extreme 1080.05
1,414.4
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/04/2013
Chairman 58 12/05/2014
Director/Board Member 66 30/01/2019
Date Insider Type Main position Quantity % Market Cap.
01/04/26 Other

Global Head of Quality and PV

35,600 0.0043%
18/12/25 Other

Director

12,717,090 1.5238%
18/12/25 Other

Director

27,618,385 3.3092%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-4.81%-8.87%+6.89% 9.97B
+0.86%+1.43%+48.50%+160.39% 1,067B
+1.59%+4.09%+55.34%+53.96% 635B
+0.95%+1.91%+35.91%+81.14% 458B
+1.60%+6.25%+33.95%+29.84% 347B
-0.60%+1.52%+35.68%+39.76% 295B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 216B
+1.22%+2.66%+21.87%+59.73% 203B
-1.18%-3.70%+14.23%+66.51% 161B
Average +0.21%+0.71%+22.45%+47.40% 365.3B
Weighted average by Cap. +0.54%+1.93%+35.69%+77.48%

Financials

2027 *2028 *
Net sales 351B 3.65B 3.2B 2.98B 2.73B 5.13B 5.21B 35.36B 13.82B 173B 13.69B 13.39B 597B 394B 4.09B 3.59B 3.34B 3.07B 5.76B 5.85B 39.69B 15.51B 194B 15.36B 15.03B 670B
Net income 37.46B 389M 342M 318M 292M 548M 556M 3.77B 1.47B 18.42B 1.46B 1.43B 63.67B 49.71B 516M 453M 422M 387M 727M 738M 5.01B 1.96B 24.44B 1.94B 1.9B 84.5B
Net Debt -31.58B -328M -288M -268M -246M -462M -469M -3.18B -1.24B -15.53B -1.23B -1.2B -53.68B -51.68B -537M -471M -438M -402M -756M -767M -5.21B -2.03B -25.41B -2.01B -1.97B -87.85B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
24/07/26 ₹1,152.60 -1.19% 230,444
23/07/26 ₹1,166.50 -1.39% 395,421
22/07/26 ₹1,183.00 -1.95% 165,968
21/07/26 ₹1,206.55 -1.37% 61,892
20/07/26 ₹1,223.30 +1.03% 52,437
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,152.60INR
Average target price
1,269.25INR
Spread / Average Target
+10.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock